BMEA Biomea Fusion, Inc.

MIXED Impact: 4/10 Institutional Cluster
Horizon weeks Processed 2d 23h ago
Institutional cluster: 6 buyers, 4 sellers (mixed)

Executive Summary

A mixed institutional cluster in BMEA for Q3 2024 shows 6 buyers (net +$2.9M) led by Marshall Wace doubling its stake to $2.5M, while 4 sellers (net +$98K) include Citadel's near-exit (-99.8%) and Legal & General's near-exit (-87.4%). The buying is concentrated among active asset managers, but the selling by sophisticated quant and multi-manager funds suggests caution. Historical performance on BMEA reports shows a 20% win rate at T+20, indicating past bullish calls have underperformed.

Key Financial Metrics

Direction
mixed
Buy Value
$3.2M
Sell Value
$98.0K
Net Flow
$2.9M

Institutional Positions

Net institutional flow: $2.9M

▲ Buyers (6)

InstitutionActionChangePosition ValueValue Δ
Marshall Wace DOUBLED +532.8% $2.5M $2.3M
Balyasny Asset Management DOUBLED +157.8% $409.0K $338.0K
Exchange Traded Concepts ADD +62.6% $212.0K $154.0K

▼ Sellers (4)

InstitutionActionChangePrev ValueValue Δ
Citadel NEAR_EXIT -99.8% $88.0K -$87.2K
Legal & General Group NEAR_EXIT -87.4% $121.0K -$86.5K
Dimensional Fund Advisors TRIM -28% $404.0K $248.0K

Actionable Insight

The cluster is mixed: active buying by Marshall Wace and Balyasny signals conviction, but Citadel's near-exit and poor historical T+20 performance on BMEA bullish calls warrant caution. Monitor for upcoming clinical catalysts or financing events that could resolve the directional uncertainty.

Key Facts

  • 6 institutional buyers added $2.9M net, led by Marshall Wace (DOUBLED to $2.5M) and Balyasny (DOUBLED to $409K)
  • 4 institutional sellers reduced by $98K net, with Citadel (NEAR_EXIT, -99.8%) and Legal & General (NEAR_EXIT, -87.4%)
  • Active asset managers dominate the buying side; sellers include a quant fund (Citadel) and a large passive manager (Dimensional)
  • Historical BMEA reports show only 20% win rate at T+20, with prior bullish calls (score 6-7) delivering negative returns

Financial Impact

6 buyers accumulated $3.2M in positions (net change +$2.9M) while 4 sellers reduced holdings by $98K net

institutional ownershipfloat

Risk Factors

  • 13F data is 45+ days stale; positions may have been unwound
  • Historical BMEA reports show low win rate (20%) at T+20, suggesting past bullish signals were premature
  • Selling by Citadel (quant) and Legal & General (passive) may reflect risk-off or thesis abandonment

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (13 analysts)

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-BMEA-2024-Q3
9 reports for BMEA
Performance horizon
50% Hit rate 2 of 4 directional calls best @ T+5▲ +15.03%Mar 31, 2026
Filters
Rows
Reports for BMEA — sortable, filterable
Type Now
Jun 12, 2026
2d ago
Institutional Cluster
MIXED ★ 4/10
$1.20 awaiting T+5awaiting T+5
Jun 5, 2026
9d ago
Press Release
BULLISH ★ 6/10
$1.29 awaiting T+5awaiting T+5
May 11, 2026
4w ago
8-K
NEUTRAL ★ 4/10
$1.58 $1.25▼ −20.89%▼ −20.96%
May 11, 2026
4w ago
Press Release
NEUTRAL ★ 5/10
$1.58 $1.25▼ −20.89%▼ −20.96%
Apr 28, 2026
6w ago
8-K
BULLISH ★ 7/10
$1.53 $1.48▼ −3.27%▼ −4.96%
Apr 27, 2026
6w ago
Press Release
BULLISH ★ 6/10
$1.53 $1.48▼ −3.27%▼ −4.96%
Mar 31, 2026
10w ago
Press Release
BULLISH ★ 7/10
$1.53 $1.76▲ +15.03%▲ +11.09%
Mar 24, 2026
11w ago
Press Release
NEUTRAL ★ 3/10
$1.22 $1.49▲ +22.13%▲ +22.37%
Feb 25, 2026
15w ago
8-K
BULLISH ★ 7/10
$1.41 $1.39▼ −1.42%▼ −0.32%
Showing 9 of 9

US Market Status

Market Closed — Opens in 3h 44m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access